NCT02594891

Brief Summary

Cholangitis is one of the main complications of endoscopic retrograde cholangiopancreatography (ERCP). Plastic biliary stent was used to prevent the occurrence of post-ERCP cholangitis, but the stent should be taken out 1-2 weeks after ERCP with endoscope again. 8.5 F plastic stent with proximal flap can discharge self-driven from biliary to the gut, it has the advantage of avoiding pulling stent out with endoscope again. The purpose of this study is to explore 8.5 F plastic stent with proximal flap on preventing post-ERCP cholangitis of ERCP in patients with choledocholithiasis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
85

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2015

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 1, 2015

Completed
Same day until next milestone

Study Start

First participant enrolled

November 1, 2015

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 3, 2015

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2016

Completed
Last Updated

May 24, 2016

Status Verified

May 1, 2016

Enrollment Period

3 months

First QC Date

November 1, 2015

Last Update Submit

May 21, 2016

Conditions

Keywords

cholangitisendoscopic retrograde cholangiopancreatographycomplication

Outcome Measures

Primary Outcomes (1)

  • Post-ERCP cholangitis

    The rate and severity of post-ERCP cholangitis will compared between two groups.

    three months

Secondary Outcomes (1)

  • adverse events

    three months

Study Arms (2)

endoscopic retrograde biliary drainage

EXPERIMENTAL

Patients will undergo endoscopic retrograde biliary drainage (ERBD) with 8.5 F plastic stent with proximal flap when bile duct stones were removed clearly with ERCP. The stent will be taken out with endoscopy three months later if not discharge self-driven.

Device: endoscopic retrograde biliary drainage

endoscopic nasobiliary drainage

PLACEBO COMPARATOR

Patients will undergo endoscopic nasobiliary drainage (ENBD) when bile duct stones were removed clearly with ERCP. The nose bile duct will be pulled out 3-5 days later if no cholangitis occurrence.

Device: endoscopic nasobiliary drainage

Interventions

A 8.5 F plastic stent with proximal flap (XinChang medical instrument co., LTD,Shanghai, China) will be inserted into common bile duct with standard procedure.

endoscopic retrograde biliary drainage

A nose bile duct(XinChang medical instrument co., LTD,Shanghai, China) will be inserted into common bile duct with standard procedure.

endoscopic nasobiliary drainage

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Obtention of a written informed consent; Patient with choledocholithiasis; Common bile duct stones are removed clearlly.

You may not qualify if:

  • No written informed consent; Combined with acute pancreatitis, acute cholangitis pre-ERCP; Patient under 18 or over 75 years.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hangzhou First People's Hospital

Hangzhou, Zhejiang, 31006, China

Location

Related Publications (1)

  • ASGE Standards of Practice Committee; Anderson MA, Fisher L, Jain R, Evans JA, Appalaneni V, Ben-Menachem T, Cash BD, Decker GA, Early DS, Fanelli RD, Fisher DA, Fukami N, Hwang JH, Ikenberry SO, Jue TL, Khan KM, Krinsky ML, Malpas PM, Maple JT, Sharaf RN, Shergill AK, Dominitz JA. Complications of ERCP. Gastrointest Endosc. 2012 Mar;75(3):467-73. doi: 10.1016/j.gie.2011.07.010. No abstract available.

    PMID: 22341094BACKGROUND

MeSH Terms

Conditions

Cholangitis

Condition Hierarchy (Ancestors)

Bile Duct DiseasesBiliary Tract DiseasesDigestive System Diseases

Study Officials

  • Xiaofeng Zhang, M.S

    First People's Hospital of Hangzhou

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Deputy irector

Study Record Dates

First Submitted

November 1, 2015

First Posted

November 3, 2015

Study Start

November 1, 2015

Primary Completion

February 1, 2016

Study Completion

February 1, 2016

Last Updated

May 24, 2016

Record last verified: 2016-05

Locations